Inflammatory and prothrombotic states in obese children of European descent

Obesity

Volumn 20, Issue 8, 2012, Pages 1662-1668

  Stoppa Vaucher, Sophie ^a   Dirlewanger, Mirjam A ^a   Meier, Christoph A ^b   De Moerloose, Philippe ^c   Reber, Guido ^c   Roux Lombard, Pascale ^c   Combescure, Christoph ^c   Saudan, Sonja ^a   Schwitzgebel, Valerie M ^a  

^a Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; D DIMER; FIBRINOGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE; INSULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTHROMBIN; THROMBIN; THROMBOPLASTIN;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOGENOUS THROMBIN POTENTIAL; ETHNIC GROUP; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; MALE; OBESITY; ONSET AGE; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTHROMBIN DEFICIENCY; PROTHROMBIN TIME; RISK ASSESSMENT; SCHOOL CHILD;

ADIPOSE TISSUE; ADOLESCENT; ATHEROSCLEROSIS; BLOOD COAGULATION DISORDERS; CHILD; CROSS-SECTIONAL STUDIES; CYTOKINES; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMOSTASIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; INTERLEUKIN-5; MALE; OBESITY; PROTHROMBIN TIME; SWITZERLAND; THROMBIN; THROMBOSIS;

EID: 84864341504     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.85     Document Type: Article

References (40)

1. Zimmermann MB, Gübeli C, Püntener C, Molinari L. Overweight and obesity in 6-12 year old children in Switzerland. Swiss Med Wkly 2004;134: 523-528.
2. Deckelbaum RJ, Williams CL. Childhood obesity: the health issue. Obes Res 2001;9(Suppl 4):239S-243S.
3. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet 2002;360:473-482.
4. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-1243.
5. Fritsch P, Kleber M, Rosenkranz A et al. Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels. Atherosclerosis 2010;212:650-655.
6. Visser M. Higher levels of inflammation in obese children. Nutrition 2001;17:480-481.
7. Nemet D, Wang P, Funahashi T et al. Adipocytokines, body composition, and fitness in children. Pediatr Res 2003;53:148-152.
8. Meier CA, Bobbioni E, Gabay C et al. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 2002;87:1184-1188.
9. Hemker HC, Giesen P, AlDieri R et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper-and hypocoagulability. Pathophysiol Haemost Thromb 2002;32:249-253.
10. Cimenti C, Mangge H, Haidl H, Zach D, Muntean W. Thrombin generation in severely obese children. J Thromb Haemost 2006;4:1834-1836.
11. Bernhard H, Deutschmann A, Leschnik B et al. Thrombin generation in pediatric patients with Crohn's disease. Inflamm Bowel Dis 2011;17: 2333-2339.
12. Matsuki T, Horai R, Sudo K, Iwakura Y. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med 2003;198:877-888.
13. Somm E, Cettour-Rose P, Asensio C et al. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia 2006;49:387-393.
14. Juge-Aubry CE, Somm E, Giusti V et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003;52:1104-1110.
15. Esposito K, Pontillo A, Giugliano F et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 2003;88:1055-1058.
16. Calcaterra V, De Amici M, Klersy C et al. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. Acta Biomed 2009;80: 117-123.
17. Larsen CM, Faulenbach M, Vaag A et al. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009;32:1663-1668.
18. Larsen CM, Faulenbach M, Vaag A et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-1526.
19. Carstensen M, Herder C, Kivimäki M et al. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes 2010;59: 1222-1227.
20. Juge-Aubry CE, Somm E, Pernin A et al. Adipose tissue is a regulated source of interleukin-10. Cytokine 2005;29:270-274.
21. Tam CS, Garnett SP, Cowell CT et al. IL-6, IL-8 and IL-10 levels in healthy weight and overweight children. Horm Res Paediatr 2010;73:128-134.
22. Ybarra J, Lehmann TN, Golay A et al. Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus. Diabetes Metab 2008;34:75-81.
23. Takahashi K, Mizuarai S, Araki H et al. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 2003;278:46654-46660.
24. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003;100:7265-7270.
25. Murdolo G, Hammarstedt A, Sandqvist M et al. Monocyte chemoattractant protein-1 in subcutaneous abdominal adipose tissue: characterization of interstitial concentration and regulation of gene expression by insulin. J Clin Endocrinol Metab 2007;92:2688-2695.
26. Kirk EA, Sagawa ZK, McDonald TO, O'Brien KD, Heinecke JW. Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue corrected. Diabetes 2008;57:1254-1261.
27. Tieu BC, Lee C, Sun H et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest 2009;119:3637-3651.
28. Meier CA, Chicheportiche R, Dreyer M, Dayer JM. IP-10, but not RANTES, is upregulated by leptin in monocytic cells. Cytokine 2003;21:43-47.
29. Gallistl S, Sudi KM, Aigner R, Borkenstein M. Changes in serum interleukin-6 concentrations in obese children and adolescents during a weight reduction program. Int J Obes Relat Metab Disord 2001;25:1640-1643.
30. Mauras N, Delgiorno C, Kollman C et al. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 2010;95:1060-1068.
31. Yeste D, Vendrell J, Tomasini R et al. Interleukin-6 in obese children and adolescents with and without glucose intolerance. Diabetes Care 2007;30:1892-1894.
32. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-214.
33. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-369.
34. Cook DG, Mendall MA, Whincup PH et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000;149:139-150.
35. Guran O, Akalin F, Ayabakan C, Dereli FY, Haklar G. High-sensitivity C-reactive protein in children at risk for coronary artery disease. Acta Paediatr 2007;96:1214-1219.
36. Tounian P, Aggoun Y, Dubern B et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001;358: 1400-1404.
37. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992;327: 1350-1355.
38. Faber CG, Lodder J, Kessels F, Troost J. Thrombin generation in platelet-rich plasma as a tool for the detection of hypercoagulability in young stroke patients. Pathophysiol Haemost Thromb 2003;33: 52-58.
39. Regnault V, Béguin S, Lecompte T. Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability. Pathophysiol Haemost Thromb 2003;33:23-29.
40. Hemker HC, Al Dieri R, De Smedt E, Béguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006;96:553-561.